United Kingdom Biotechnology & Medical Research

TheraCryf PLC (TCF)

Track

Track

Ticker: TCF Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Dr Nicholas Mallard PDMR
Transaction date
Purchase
Price
489.32
Quantity 20,445
Value £1,076,293
Glen Clack Chief Medical Officer Officer
Transaction date
Purchase
Price
54.54
Quantity 31,641
Value £4,826,186
Dr Helen Kuhlman Chief Business Officer Officer
Transaction date
Purchase
Price
487.61
Quantity 59,094
Value £2,933,662
Dr Susan Foden Non-Executive Chair Director
Transaction date
Purchase
Price
0.01
Quantity 600,000
Value £6,000
Toni Hänninen Chief Financial Officer Officer
Transaction date
Purchase
Price
0.01
Quantity 1,000,000
Value £10,000
Dr Huw Jones Chief Executive Officer Officer
Transaction date
Purchase
Price
0.01
Quantity 3,000,000
Value £30,000
Dr Huw Jones Chief Executive Officer Officer
Transaction date
Purchase
Price
0.01
Quantity 122,293
Value £1,761
Richard Moulson CFO Officer
Transaction date
Purchase
Price
0.08
Quantity 3,787
Value £303
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-04-05 2024-04-05 B Purchase Dr Nicholas Mallard

PDMR
20,445
489.32
£1,076,293 		20,445 489.32 £1,076,293
2024-04-05 2024-04-05 B Purchase Glen Clack

Chief Medical Officer

Officer
31,641
54.54
£4,826,186 		31,641 54.54 £4,826,186
2024-04-05 2024-04-05 B Purchase Dr Helen Kuhlman

Chief Business Officer

Officer
59,094
487.61
£2,933,662 		59,094 487.61 £2,933,662
2024-04-05 2024-04-05 B Purchase Dr Susan Foden

Non-Executive Chair

Director
600,000
0.01
£6,000 		600,000 0.01 £6,000
2024-04-05 2024-04-05 B Purchase Toni Hänninen

Chief Financial Officer

Officer
1,000,000
0.01
£10,000 		1,000,000 0.01 £10,000
2024-04-05 2024-04-05 B Purchase Dr Huw Jones

Chief Executive Officer

Officer
3,000,000
0.01
£30,000 		3,000,000 0.01 £30,000
2024-04-05 2024-04-05 B Purchase Dr Huw Jones

Chief Executive Officer

Officer
122,293
0.01
£1,761 		122,293 0.01 £1,761
2021-03-05 2021-03-03 B Purchase Richard Moulson

CFO

Officer
3,787
0.08
£303 		3,787 0.08 £303
Explore more

More insider trading research around TheraCryf PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe